The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has granted conditional marketing authorization (MA) for ...

Shanghai Fosun Pharmaceutical has entered into a license agreement with Sitala, a UK-based biotech company focused on ...

The US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) to Rina-S (rinatabart sesutecan) ...

US pharma major Eli Lilly today announced positive top-line results from the primary overall survival (OS) analysis of the ...

California-based Therna Biosciences has announced its launch with the stated vision to transform the development of RNA ...

US antivirals specialist Gilead Sciences yesterday announced that the European Commission (EC) has granted marketing ...

Chinese biopharma Akeso has presented the final analysis of the Phase III HARMONi-A lung cancer study of ivonescimab, ...

Regeneron Pharmaceuticals’ shares closed up 2.7% to $587.65 as it announced that the primary and key secondary endpoints were ...

The European Commission (EC) has approved Chinese biopharma Bio-Thera Solutions BAT2206 (ustekinumab), a biosimilar ...

A clinical-stage biotech company headquartered in San Diego, focused on advancing RNA-based medicines for serious and ...

Netherlands-based Scenic Biotech has announced a license and research agreement with Alnylam Pharmaceuticals to leverage Scenic’s Cell-Seq platform for discovering novel targets for RNAi therapeutics.